What is the treatment for migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Migraines

For acute migraine treatment, combination therapy of a triptan and an NSAID or acetaminophen is recommended for nonpregnant adults with inadequate response to NSAID or acetaminophen monotherapy, as this provides superior relief compared to monotherapy. 1, 2

First-Line Treatment Algorithm

Mild to Moderate Migraine Attacks

  1. NSAIDs or Acetaminophen

    • Ibuprofen 400-600mg
    • Naproxen sodium 500-550mg
    • Aspirin 800-1000mg
    • Acetaminophen (appropriate dosage) 2
  2. If inadequate response:

    • Consider increasing dosage (without exceeding maximum daily dose)
    • Add a triptan (see combination therapy below) 1

Moderate to Severe Migraine Attacks

  1. Triptan monotherapy (effective but less beneficial than combination therapy)

    • Sumatriptan 50mg orally (for most patients)
    • Sumatriptan 6mg subcutaneously (for severe attacks or significant nausea/vomiting)
    • Rizatriptan 10mg orally 2, 3
  2. Preferred: Combination therapy

    • Triptan (sumatriptan or rizatriptan) + NSAID (naproxen) OR
    • Triptan + acetaminophen 1, 2

Second-Line Options

  • CGRP Antagonists (Gepants) such as rimegepant, ubrogepant, or zavegepant
  • Ditans (lasmiditan)
  • Antiemetics (for associated nausea/vomiting) 2

Evidence Quality and Effectiveness

The American College of Physicians' 2025 clinical guideline provides strong evidence that combination therapy of a triptan with an NSAID or acetaminophen has greater net benefit than triptan monotherapy 1. Clinical trials demonstrate that sumatriptan is effective in 50-67% of patients with oral administration and 70-80% with subcutaneous administration 3, 4.

Triptans work rapidly, with headache relief often beginning within 1-2 hours of administration. FDA data shows that sumatriptan provides headache response (reduction from moderate/severe to mild/no pain) in 50-62% of patients at 2 hours and 65-79% at 4 hours, compared to only 17-27% with placebo at 2 hours 3.

Important Considerations and Caveats

Timing of Administration

  • Begin treatment as early as possible after headache onset for best results 2
  • Medications are most effective when taken during the mild pain phase rather than waiting until pain is severe

Medication Overuse Prevention

Limit acute medications to prevent medication overuse headache:

  • Triptans: No more than 9 days per month
  • NSAIDs: No more than 15 days per month
  • OTC medications: No more than 14 days per month 2

Contraindications

  • Triptans are contraindicated in patients with ischemic heart disease, angina, previous myocardial infarction, and uncontrolled hypertension 4
  • For patients with vascular contraindications, gepants and ditans may be appropriate alternatives as they don't have vascular contraindications 5

Recurrence Management

Approximately 40% of patients who initially respond to sumatriptan may experience headache recurrence within 24 hours, but most respond well to a second dose 4

Preventive Treatment

For patients with frequent migraines (≥2 attacks per month with disability lasting ≥3 days), consider preventive therapy:

  • First-line preventive options:

    • Beta blockers (propranolol is FDA-approved for migraine prophylaxis) 6
    • Topiramate
    • Candesartan
    • Amitriptyline
    • Divalproex sodium 2
  • For chronic migraine prevention:

    • CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) 2

Non-Pharmacological Approaches

  • Regular exercise (aerobic, strength training, yoga)
  • Sleep hygiene education
  • Adequate hydration
  • Identification and avoidance of triggers
  • Relaxation techniques or mindfulness
  • Cognitive Behavioral Therapy 2

These non-pharmacological approaches should complement, not replace, appropriate pharmacological treatment for acute attacks.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Headache Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Migraine Headache: Treatment Strategies.

American family physician, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.